Featured Research

from universities, journals, and other organizations

World's toughest bacterium holds promise for rapid vaccine development against deadly diseases

Date:
July 18, 2012
Source:
Uniformed Services University of the Health Sciences (USU)
Summary:
Scientists have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A lethally irradiated vaccine was successfully tested in mice against drug-resistant Staphylococcus aureus (MRSA) bacteria and holds promise for other such deadly diseases.

The scientists used the Mn-peptide complex in a laboratory setting to successfully protect from radiation damage the protein epitopes of Venezuelan equine encephalitis virus, a microbe that causes a mosquito- borne disease of the nervous system. They also used the preparation method to develop an effective vaccine against methicillin-resistant S. aureus (MRSA) infections in mice.
Credit: Image courtesy of USU

Scientists from the Uniformed Services University of the Health Sciences (USU) have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A vaccine exposed to megadoses of gamma radiation was successfully tested in mice against drug-resistant Staphylococcus aureus bacteria by colleagues at the National Institutes of Health (NIH), and holds promise for other such deadly diseases.

Related Articles


The results of the breakthrough study were published in the July edition of Cell Host and Microbe.

High doses of radiation typically destroy a pathogen's genome, rendering it unable to cause infection when used in a vaccine. However, radiation also damages a microbe's protein epitopes, which the immune system must recognize for a vaccine to be protective. Organisms inactivated, or killed, by radiation trigger better immune responses than those inactivated by traditional heat or chemical methods. Although live vaccines may provide better immune protection than irradiated vaccines, live vaccines are frequently not an option as they can carry an unacceptable risk of infection with an otherwise untreatable disease (e.g., HIV). Lethally irradiated vaccines could also help the developing world, where the need for cold storage limits the availability of live vaccines.

To separate genome destruction from epitope survival, the researchers borrowed some complex chemistry from the world's toughest bacterium Deinococcus radiodurans, nicknamed "Conan the Bacterium," which can withstand 3,000 times the radiation levels that would kill a human being. In 2000, Deinococcus was engineered for cleanup of highly radioactive wastes left over from the production of atomic bombs. Now, unusual Mn(II)-antioxidants discovered in this extremophile have been successfully applied to preparing irradiated vaccines.

Deinococcus accumulates high concentrations of manganese and peptides, which the scientists combined in the laboratory -- forming a potent antioxidant complex which specifically protects proteins from radiation. They found that the complex preserves immune-related epitopes when applied to viruses and bacteria during exposure to gamma radiation, but did not protect their genomes.

Michael J. Daly, Ph.D., professor of Pathology at USU, and his research team, collaborated on the work with Sandip K. Datta, M.D., and colleagues at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Daly devoted 20 years to studying Deinococcus radiodurans, which has led to three patents for his work.

The scientists used the Mn-peptide complex in a laboratory setting to successfully protect from radiation damage the protein epitopes of Venezuelan equine encephalitis virus, a microbe that causes a mosquito- borne disease of the nervous system. They also used the preparation method to develop an effective vaccine against methicillin-resistant S. aureus (MRSA) infections in mice.

Learning to Care for Those in Harm's Way

The researchers believe the whole-microbe vaccine approach could extend to any infectious organism that can be cultivated, whether fungi, parasites, protozoa, viruses or bacteria -- including agents that mutate rapidly, such as pandemic influenza and HIV. The groups aim to demonstrate this method of irradiation as a rapid, cost-effective approach to vaccine development.

The project was funded by the Air Force Office of Scientific Research (AFOSR) and the intramural research program of the NIAID.


Story Source:

The above story is based on materials provided by Uniformed Services University of the Health Sciences (USU). Note: Materials may be edited for content and length.


Journal Reference:

  1. Elena K. Gaidamakova, Ian A. Myles, Dennis P. McDaniel, Cedar J. Fowler, Patricia A. Valdez, Shruti Naik, Manoshi Gayen, Paridhi Gupta, Anuj Sharma, Pamela J. Glass, Radha K. Maheshwari, Sandip K. Datta, Michael J. Daly. Preserving Immunogenicity of Lethally Irradiated Viral and Bacterial Vaccine Epitopes Using a Radio- Protective Mn2 -Peptide Complex from Deinococcus. Cell Host & Microbe, 2012; 12 (1): 117 DOI: 10.1016/j.chom.2012.05.011

Cite This Page:

Uniformed Services University of the Health Sciences (USU). "World's toughest bacterium holds promise for rapid vaccine development against deadly diseases." ScienceDaily. ScienceDaily, 18 July 2012. <www.sciencedaily.com/releases/2012/07/120718122728.htm>.
Uniformed Services University of the Health Sciences (USU). (2012, July 18). World's toughest bacterium holds promise for rapid vaccine development against deadly diseases. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2012/07/120718122728.htm
Uniformed Services University of the Health Sciences (USU). "World's toughest bacterium holds promise for rapid vaccine development against deadly diseases." ScienceDaily. www.sciencedaily.com/releases/2012/07/120718122728.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins